Home Carboxes 5651-14-9
5651-14-9,MFCD05663337
Catalog No.:AA00E99L

5651-14-9 | Naphthalene-2-carboxamidine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
94%
3 weeks  
$250.00   $175.00
- +
100mg
94%
3 weeks  
$317.00   $222.00
- +
250mg
94%
3 weeks  
$404.00   $283.00
- +
500mg
94%
3 weeks  
$668.00   $468.00
- +
1g
94%
3 weeks  
$854.00   $598.00
- +
2.5g
94%
3 weeks  
$1,561.00   $1,093.00
- +
5g
94%
3 weeks  
$2,256.00   $1,579.00
- +
10g
94%
3 weeks  
$3,290.00   $2,303.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00E99L
Chemical Name:
Naphthalene-2-carboxamidine
CAS Number:
5651-14-9
Molecular Formula:
C11H10N2
Molecular Weight:
170.2105
MDL Number:
MFCD05663337
SMILES:
NC(=N)c1ccc2c(c1)cccc2
Properties
Computed Properties
 
Complexity:
200  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
2.7  

Literature

Title: Protease activity increases in plasma, peritoneal fluid, and vital organs after hemorrhagic shock in rats.

Journal: PloS one 20120101

Title: MicroRNA regulation of human protease genes essential for influenza virus replication.

Journal: PloS one 20120101

Title: Large-scale application of high-throughput molecular mechanics with Poisson-Boltzmann surface area for routine physics-based scoring of protein-ligand complexes.

Journal: Journal of medicinal chemistry 20090528

Title: Urokinase separation from cell culture broth of a human kidney cell line.

Journal: International journal of biological sciences 20070101

Title: Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator.

Journal: BMC chemical biology 20060101

Title: Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties.

Journal: Bioorganic & medicinal chemistry letters 20050103

Title: Interaction with the S1 beta-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20040621

Title: Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution.

Journal: Journal of medicinal chemistry 20040115

Title: Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters 20030224

Title: Inhibitors of the protease domain of urokinase-type plasminogen activator.

Journal: Current pharmaceutical design 20020101

Title: Species specificity of amidine-based urokinase inhibitors.

Journal: Biochemistry 20010807

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:5651-14-9 Molecular Formula|5651-14-9 MDL|5651-14-9 SMILES|5651-14-9 Naphthalene-2-carboxamidine